Prostate Cancer - Results from #24920

Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis - Abstract August 31, 2012

Effect of body mass index on intrafraction prostate displacement monitored by real-time electromagnetic tracking - Abstract August 31, 2012

Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the Randomised FinnProstate Study VII: Quality of life and adverse effects - Abstract August 31, 2012

Presidential Proclamation -- National Prostate Cancer Awareness Month, 2012 August 31, 2012

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer - Abstract August 31, 2012

Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option? - Abstract August 31, 2012

The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy - Abstract August 30, 2012

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: Analysis of trends over time - Abstract August 30, 2012

Can a Gleason 6 or less microfocus of prostate cancer in one biopsy and prostate-specific antigen level August 30, 2012

Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer - Abstract August 30, 2012

Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies - Abstract August 30, 2012

Towards the use of non-psychoactive cannabinoids for prostate cancer - Abstract August 30, 2012

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium - Abstract August 30, 2012

Dietary cadmium exposure and prostate cancer incidence: A population-based prospective cohort study - Abstract August 30, 2012

Charlie Wilson teams up with Janssen Biotech to launch Making Awareness a Priority (M.A.P.) August 30, 2012

Immunotherapy for prostate cancer enters its golden age - Abstract August 30, 2012

Oncological and functional results of extraperitoneal laparoscopic radical prostatectomy - Abstract August 30, 2012

Handling of radical prostatectomy specimens: Total embedding with large-format histology - Abstract August 30, 2012

Current and emerging treatments in the management of castration-resistant prostate cancer - Abstract August 30, 2012

Hypofractionated radiotherapy in prostate cancer - Abstract August 30, 2012

Page 1247 of 1436